A. Haşimi Et Al. , "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients," Biochemia medica , vol.33, no.1, pp.10701, 2023
Haşimi, A. Et Al. 2023. Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients. Biochemia medica , vol.33, no.1 , 10701.
Haşimi, A., DOĞAN, Ö., Serdar, C. C., & SERDAR, M. A., (2023). Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients. Biochemia medica , vol.33, no.1, 10701.
Haşimi, Adnan Et Al. "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients," Biochemia medica , vol.33, no.1, 10701, 2023
Haşimi, Adnan Et Al. "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients." Biochemia medica , vol.33, no.1, pp.10701, 2023
Haşimi, A. Et Al. (2023) . "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients." Biochemia medica , vol.33, no.1, p.10701.
@article{article, author={Adnan Haşimi Et Al. }, title={Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients}, journal={Biochemia medica}, year=2023, pages={10701} }